NextPlat Corp. (NASDAQ:NXPL) Short Interest Down 32.5% in December

by · The Markets Daily

NextPlat Corp. (NASDAQ:NXPL – Get Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totaling 199,110 shares, a drop of 32.5% from the November 30th total of 294,871 shares. Currently, 1.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 217,370 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily trading volume, of 217,370 shares, the days-to-cover ratio is currently 0.9 days. Currently, 1.4% of the shares of the stock are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NextPlat stock. Simplicity Wealth LLC purchased a new stake in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned about 2.31% of NextPlat as of its most recent SEC filing. Institutional investors and hedge funds own 1.30% of the company’s stock.

NextPlat Trading Up 1.5%

Shares of NXPL stock traded up $0.01 on Tuesday, hitting $0.56. 153,637 shares of the company’s stock traded hands, compared to its average volume of 327,963. The stock has a market capitalization of $14.77 million, a price-to-earnings ratio of -1.87 and a beta of 1.16. The company’s fifty day simple moving average is $0.69 and its 200 day simple moving average is $0.73. NextPlat has a one year low of $0.43 and a one year high of $2.30. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56.

NextPlat (NASDAQ:NXPL – Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $13.75 million for the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, NextPlat has a consensus rating of “Sell”.

Check Out Our Latest Report on NXPL

NextPlat Company Profile

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

Read More